Bone Marrow Transplantation: A Novel Treatment for HIV Seropositives

Slides:



Advertisements
Similar presentations
Emerging patterns of drug resistance and viral tropism in cART-naïve and failing patients infected with HIV-1 subtype C Thumbi Ndung’u, BVM, PhD Associate.
Advertisements

Evaluation of Human Thymic Function during Health and HIV-1 Infection
Therapy of enzyme defects: general considerations ● How many organs are affected by the enzyme defect: One organ, a few, or all organs? ● How severe is.
CCR5 : and HIV Immunity Gene Variation Works for and Against HIV Ashley Alexis & Hilda Hernandez.
HIV/AIDS as a Microcosm for the Study of Evolution.
Natural Selection in Human Populations
HIV and AIDS Human Immunodeficiency Virus (HIV) is the virus that causes Acquired Immunodeficiency Syndrome (AIDS).
Lecture: HIV I.Motivation What can we learn when we apply evolutionary principles to our understanding of the of the HIV epidemic?? Can we use HIV to introduce.
Current HIV basic science research topics. Toddler "Functionally Cured" of HIV Infection- “the Mississippi Baby” First well-documented case of an HIV.
Hematopoietic stem cell based gene therapy for HIV diseases
Introduction to Basic Science of HIV/AIDS. BREAKDOWN OF HIV RESEARCH BASIC SCIENCEBASIC SCIENCE Seeks the fundamental understanding of the biological,
By Taylor, Lanny, and Alex. What is it?  Leukemia is an abnormal rise in the number of white blood cells. The white blood cells crowd out other blood.
HIV Notes HIV particles (grey) covering a white blood cell.
Defense Against Infectious Disease How does my body fight disease?
The Immune System Unit 3 Transportation Systems.
Viruses Chapter Nature of Viruses All viruses have same basic structure -Nucleic acid core surrounded by capsid Nucleic acid can be DNA or RNA;
1 Body Defenses, Immunity & Vaccines Chapter The Immune System Protects us from harmful agents and is made up if blood cells and the lymphatic system.
HIV & AIDS Pages ; IB Topic 6.3. Turn and Talk What do you know or think of HIV & AIDS?
The evolution of HIV Why is HIV fatal?. Lethal strains are favored, due to “Short sighted” evolution within hosts Transmission rate advantages.
Why study evolution?  Best conceptual framework for understanding origins of biodiversity  Adaptations that allow organisms to exploit their environment.
The Berlin Patient and CCR5. Tim Brown: the only man to have been cured of HIV  Brown was diagnosed with HIV in 1995  11 years on antiretroviral therapy.
MONDAY 1 DECEMBER 2009 WORLD AIDS DAY. HIV / AIDS HUMAN IMMUNODEFICIENCY VIRUS ACQUIRED IMMUNE DEFICIENCY SYNDROME.
Using Stem Cells to Treat Disease The first step: establish stem cell lines (large groups of the same cells) Next: turn on specific genes so that the stem.
Has someone been cured of HIV?. Some background on HIV O Causes AIDS O Mutates rapidly O Infects T cells of the immune system O Lysogenic (can hide inside.
HIV & AIDS.  Topic Question: Will AIDS or HIV ever be cured in our lifetime?  Product: Volunteer at the North Carolina Food Bank.
Chapter 10 An Evolving Enemy Silvio Penta Silvio Penta Christie DiDonato Christie DiDonato Carl Tuoni Carl Tuoni Beth Miller Beth Miller.
Mr. Phipps U.S. History. AIDS Definition: Acquired Immuno Deficiency Syndrome –AIDS is a severe immunological disorder caused by HIV – Transmitted primarily.
Why study evolution?  Best conceptual framework for understanding origins of biodiversity  Adaptations that allow organisms to exploit their environment.
EVOLUTIONARY ANALYSIS 1. To show the kind of questions evolutionary biologist investigate. 2. Demonstrate how an evolutionary view can inform researchers.
HIV/AIDS HIV/AIDS Rate per 100,000 people Plan for Tonight Unit 6 and 7 Work Immune Response HIV’s Interaction with the Immune System Difficulties with.
Research on killer HIV antibodies provides promising new ideas for vaccine design New discoveries about the immune defenses of rare HIV patients who produce.
IAS Members Meeting July 19th 2011 Achievements and learning over the past 30 years: what do we need next? Françoise BARRÉ-SINOUSSI Regulation of Retroviral.
HIV/AIDS Vianca Rivera HPA 310 Final Project
HIV/AIDS.
THE IMMUNE RESPONSES TO VIRUSES
Immune reconstitution Anjie Zhen, PhD
Beginning of the chapter HIV resistance and genetics (HIV RESISTANCE SENSOR) 57.
Immune system. Human immunodeficiency virus (HIV)
Animal Viruses –Viruses that infect animals are common causes of disease. –From Medical Virology 4th Ed. By White and Fenner.
Create a concept map of the adaptive immune system.
Journal Club Presentation BIOL368/F16: Bioinformatics Laboratory
Abstract MOAB0301 Hepatitis C Care Cascade for People Living With HIV in the Country of Georgia Nikoloz Chkhartishvili1, A. Abutidze1, N. Bolokadze1, O.
Evolution is the unifying concept of biology
Stem Cell Factor (SCF) for Viral or Genetic Disorders
Enzyme and gene therapy of enzyme defects
HIV susceptibility and CCR5
AIDS Chien-Ming Li MD, Ph.D.
Katsin MA, Vitebsk State Medical University (Belarus)
What’s Your Health IQ? True or False
Autoimmunity: Introduction
Therapy of enzyme defects: general considerations
Human Imunnodeficiency Virus
Christopher S. Lathan, M. D. , M. S. , M. P. H
Ethics in Biotechnology
by David P. Steensma, Rafael Bejar, Siddhartha Jaiswal, R
Human Health and Disease
Testing The test is for antibodies against HIV, not for the virus itself. It can take up to three months for the body to produce antibodies against HIV.
HIV & AIDS GENERAL AWARENESS
Leukemia is characterized by abnormal white blood cells.
Monique Nijhuis University Medical Center Utrecht, the Netherlands
Antibiotics are designed to : cell walls and membranes
Taking Advantage of the Systemic Immune System to Cure Brain Diseases
Emergence of resistance to immune checkpoint blockade is associated with elimination of mutation-associated neoantigens by LOH and a more diverse T-cell.
ئەيدىز كېسىلى (AIDS) مەمەتئىمىن دوكتۇر.
Aim What happens when a bacteria or virus mutates?
Enzyme and gene therapy of enzyme defects
Leukemia By: Fabiola Dominguez.
Management of HIV/AIDS
QUiZ Questions -HIV And AiDS
PubMed Research Article
Presentation transcript:

Bone Marrow Transplantation: A Novel Treatment for HIV Seropositives Singh A.1, Pal R.1, Verma A.S.2 1Amity Institute of Biotechnology , Amity University Uttar Pradesh, Sector-125, NOIDA, UP, India 2 Pro-Vice-Chancellor, Jadavpur University 188 Raja S C Mallik Road, Jadavpur, Kolkata WB, India ABSTRACT INTRODUCTION After four years of bone marrow transplantation the patient has remained free of HIV and immune reconstitution has been observed. This type of treatment can be helpful for those who do not respond to anti-retroviral treatment. HIV infection is always dealt with fretfulness, because HIV infections lead to an incurable disease commonly known as Acquired Immuno-deficiency Syndrome (AIDS). A full blown AIDS is the final chapter of an individual infected with HIV . Still, the fact remains as “HIV Infections can be controlled and cannot be cured”. In the recent past, it has been reported that an HIV seropositive has been cured of HIV by transplanting a bone marrow with mutation CCR5 32/ 32. So far, it is considered as interesting observation in case of incurable infections like HIV. This patient has remained HIV-free since last 4 years. To date, all efforts to cure HIV by diverse means have not proven successful to cure HIV infections. Although bone marrow transplantation has shown some promises to cure HIV in future. There are skepticism about this modality of treatment in the form of HIV rebound, evolution of X-4 strain and even the possibilities of activation of HIV from a long-term reservoir , etc. Bone marrow transplantation has opened new vistas and generated a hope for HIV patients, but there are real limitations to evolve bone marrow transplantation as a modality to treat HIV infections e.g., this mutation exists in few cases and that only in Caucasian population. This successful report warrants expansion of research in the direction to search and find similar mutation among other races ,which are badly affected by HIV. At present bone marrow transplantation is a good option for those patients who do not respond to HAART or are in terminal stages of HIV infection and happen to have the option of a rare donor of this CCR5 genotype. It had been observed that certain individuals do not get infected with HIV even though they were exposed to HIV numerous times. These individuals are considered as having natural resistance against HIV infections. .HIV affects specific cells of the immune system, called CD4+ cells, or T cells. CD4 is the primary receptor for HIV infections, but chemokine receptors like CXCR4 and CCR5 have been shown to be essential for HIV infections. The natural resistance to HIV infections is attributable to mutation in co-receptor CCR5 sequence. Though, this mutation has been attributed to low frequency of ~1% among the Caucasian race only. REFERENCES Hutter G, Nowsak D, Mossner M et al. Long term control of HIV by CCR5 delta32/delta32 stem-cell transplantation. N Engl J Med, 2009, 360: 692-698. Allers K. Hutter G, Hoffman J et al. Evidence for the cure of HIV infections by CCR5 32/32 stem cell transplantation. Blood, 2010, 201, 2791-2799. Verma AS, Singh A. Bone Marrow Transplantation : A New Avenue to Cure HIV. 2011, Blood 117:10. UNAIDS Report-2009. Verma AS, Singh I, Bansal R, Singh A. HIV and Anti-retroviral Drugs. In: Verma AS and Singh A Animal Biotechnology: Models in Discovery and Translation. Academic Press, 2014, 155-176. Verma AS, Singh A,. HIV: An Introduction. In: Varma A, Chauhan AK, editors. Text book on molecular biotechnology. Delhi: I.K. International Publishing House Pvt. Ltd.; 2009, 853-78. Ryser HJP, & Fluckiger R. Progress in targeting HIV-1 entry. Drug Discovery Today, 2005, 10, 1085–1094. The patient was a 40 years old male HIV seropositive under anti-HIV treatment. HIV infection was under control but the patient was suffering from AML for which he had to undergo bone marrow transplantation. The patient was transplanted with a donor having homozygous mutation in CCR5 gene so the patient may become naturally resistant to HIV. ACKNOWLEDGEMENTS The authors are thankul to Mr. Dinesh Kumar for his secretarial assistance.